CD33 and Alzheimer disease: Loss-of-function of the CD33 gene was associated with reduction of insoluble Aβ levels in the AD brain, and increased levels of CD33 protein were observed in post-mortem samples of brain from AD patients (Bradshaw et al., 2013).